Key Takeaways
- • KKR is in advanced talks to acquire Medicover's entire 66.9% stake in Medicover Hospitals India for at least $1.05 billion, with discussions also underway with minority shareholders to secure majority control of the Indian operations.
- • Medicover Hospitals India operates a 26-hospital network with approximately 6,000 beds across India, having entered the market in 2016; the deal would represent one of the largest healthcare transactions in the country and signal growing PE appetite for Indian hospital assets.
- • A non-binding agreement has been reached between the parties, though Medicover stated there is no certainty the discussions will result in a completed transaction and the company is continuing parallel preparations for an IPO in late 2026 or 2027.
- • The acquisition would expand KKR's healthcare investment footprint in India, the world's most populous nation, amid a broader surge in healthcare sector FDI (hospitals absorbed approximately half of India's total healthcare FDI of ~$1.5 billion in FY24).
Summary
KKR, the multinational private equity and investment firm, is in advanced negotiations to acquire a controlling stake in Medicover Hospitals India, the Indian subsidiary of Sweden-listed healthcare company Medicover. According to Reuters reporting on June 18, 2026, KKR is seeking to purchase Medicover's full 66.9% ownership stake in the Indian business for a minimum valuation of $1.05 billion, while simultaneously negotiating with minority shareholders to establish majority control. A non-binding agreement has been reached between the parties, though final terms remain subject to continued discussions.
Medicover Hospitals India operates a significant healthcare footprint with 26 hospitals and approximately 6,000 beds across India. The Swedish parent company entered the Indian market in 2016 and has since established itself as a material player in the country's hospital sector. The proposed transaction would constitute one of the largest healthcare sector deals in India and underscores accelerating global investor interest in Indian healthcare infrastructure. According to market data, hospitals absorbed roughly half of India's total healthcare foreign direct investment in fiscal year 2024, approximately $1.5 billion, reflecting a sharp increase in sector attractiveness to institutional and PE investors.
A complicating factor is Medicover's stated intention to pursue an initial public offering of its Indian operations in late 2026 or 2027. In its official statement responding to Reuters' inquiry, the company emphasized that discussions with KKR carry no certainty of completion and that IPO preparations are continuing in parallel. This dual-track approach provides optionality but also introduces execution uncertainty. Medicover and KKR both declined to comment beyond the Swedish parent company's confirmation that discussions regarding a potential sale are ongoing. The non-binding status of current agreements means either party retains flexibility to alter course should terms, valuations, or market conditions shift materially.
The potential acquisition aligns with KKR's broader strategy of expanding healthcare exposure in high-growth markets, particularly India's expanding middle class and rising healthcare expenditure. For Medicover, the transaction would provide liquidity and capital for the Swedish parent while potentially accelerating growth initiatives in India under PE ownership. Market participants will monitor for definitive agreement announcements, regulatory clearances, and any clarification on IPO timeline revisions in coming months.
Medicover Hospitals India operates a significant healthcare footprint with 26 hospitals and approximately 6,000 beds across India. The Swedish parent company entered the Indian market in 2016 and has since established itself as a material player in the country's hospital sector. The proposed transaction would constitute one of the largest healthcare sector deals in India and underscores accelerating global investor interest in Indian healthcare infrastructure. According to market data, hospitals absorbed roughly half of India's total healthcare foreign direct investment in fiscal year 2024, approximately $1.5 billion, reflecting a sharp increase in sector attractiveness to institutional and PE investors.
A complicating factor is Medicover's stated intention to pursue an initial public offering of its Indian operations in late 2026 or 2027. In its official statement responding to Reuters' inquiry, the company emphasized that discussions with KKR carry no certainty of completion and that IPO preparations are continuing in parallel. This dual-track approach provides optionality but also introduces execution uncertainty. Medicover and KKR both declined to comment beyond the Swedish parent company's confirmation that discussions regarding a potential sale are ongoing. The non-binding status of current agreements means either party retains flexibility to alter course should terms, valuations, or market conditions shift materially.
The potential acquisition aligns with KKR's broader strategy of expanding healthcare exposure in high-growth markets, particularly India's expanding middle class and rising healthcare expenditure. For Medicover, the transaction would provide liquidity and capital for the Swedish parent while potentially accelerating growth initiatives in India under PE ownership. Market participants will monitor for definitive agreement announcements, regulatory clearances, and any clarification on IPO timeline revisions in coming months.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.